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Abstract
Focal adhesion kinase (FAK) is a key component of the membrane
proximal signaling layer in focal adhesion complexes, regulating
important cellular processes, including cell migration, prolifera-
tion, and survival. In the cytosol, FAK adopts an autoinhibited
state but is activated upon recruitment into focal adhesions, yet
how this occurs or what induces structural changes is unknown.
Here, we employ cryo-electron microscopy to reveal how FAK
associates with lipid membranes and how membrane interactions
unlock FAK autoinhibition to promote activation. Intriguingly,
initial binding of FAK to the membrane causes steric clashes that
release the kinase domain from autoinhibition, allowing it to
undergo a large conformational change and interact itself with
the membrane in an orientation that places the active site
toward the membrane. In this conformation, the autophosphory-
lation site is exposed and multiple interfaces align to promote
FAK oligomerization on the membrane. We show that interfaces
responsible for initial dimerization and membrane attachment
are essential for FAK autophosphorylation and resulting cellular
activity including cancer cell invasion, while stable FAK oligomer-
ization appears to be needed for optimal cancer cell proliferation
in an anchorage-independent manner. Together, our data provide
structural details of a key membrane bound state of FAK that is
primed for efficient autophosphorylation and activation, hence
revealing the critical event in integrin mediated FAK activation
and signaling at focal adhesions.
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Introduction
Focal adhesions are large protein complexes that assemble at the
cytoplasmic side of the plasma membrane and connect the actin
cytoskeleton inside the cell via integrin trans-membrane receptors to
the extracellular matrix outside the cell. The complex plays an
important mechanical role during mesenchymal cell migration,
where contraction of actomyosin stress fibers attached to focal adhe-
sions build up a force that is transmitted via the focal adhesion
complex to the extracellular matrix to gain traction needed for cell
motility (Sun et al, 2016). For this to occur in an orderly fashion,
allowing for concerted focal adhesion assembly at the leading edge
and disassembly at the rear (Wehrle-Haller, 2012), an extensive
signaling network is associated with focal adhesions, which at the
systems level is integrated with other signaling networks that
control proliferation and survival (Winograd-Katz et al, 2014). To
fulfill these multiple roles, focal adhesions adopt a layered architec-
ture, where actin fibers attach to a membrane distal actin regulatory
layer that is connected to integrin receptors and a membrane proxi-
mal signaling layer via a force transduction layer (Kanchanawong
et al, 2010). Focal adhesion kinase (FAK) is a key component of the
signaling layer and acts as a hub that integrates signaling at focal
adhesions. FAK is both a scaffold protein and a non-receptor tyro-
sine kinase that is essential during development and plays key func-
tions in tissue repair and wound healing (Ilic et al, 1995; Ashton
et al, 2010; Ransom et al, 2018; Toro-Tapia et al, 2018). FAK is
overexpressed in numerous human tumors and is in particular
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implicated in tumor invasion and metastasis (Provenzano & Keely,
2009; Sulzmaier et al, 2014). FAK also provides survival signals
causing tumor resistance (Tavora et al, 2014; Hirata et al, 2015;
Jiang et al, 2016; Diaz Osterman et al, 2019); hence, FAK has been
considered an important target for anti-cancer therapies (Sulzmaier
et al, 2014; Lv et al, 2018).
Focal adhesion kinase shares its domain structure with the
closely related proline-rich tyrosine kinase 2 (Pyk2), both contain
an N-terminal FERM (band 4.1, ezrin, radixin, moesin homology)
domain, a central kinase domain, and a C-terminal focal adhesion
targeting (FAT) domain (Fig 1A). Whereas the FAT domain is
responsible for targeting FAK into focal adhesions (Arold et al,
2002; Hayashi et al, 2002; Gao et al, 2004), the FERM domain of
FAK plays a central role in regulating FAK function (Cooper et al,
2003; Dunty et al, 2004) and is an interaction domain that allows
FAK to integrate signals from various sources (Zaidel-Bar et al,
2007; Frame et al, 2010; Horton et al, 2015). In the autoinhibited
state, the FERM domain forms intramolecular interactions with the
kinase domain that occludes the active site and sequesters impor-
tant regulatory phosphorylation sites (Lietha et al, 2007). In this
state, FAK can form FERM-mediated dimers that are stabilized by
FAT interactions with the FERM domain (Brami-Cherrier et al,
2014). Signals emanating from growth factors and integrins lead to
activation of FAK (Sulzmaier et al, 2014; Walkiewicz et al, 2015),
but also mechanical inputs in form of stretching forces generated in
focal adhesions appear important for FAK activation (Wang et al,
2001; Torsoni et al, 2003; Seong et al, 2013; Bauer et al, 2019).
Located in the membrane proximal signaling layer in focal adhe-
sions, FAK directly interacts with the membrane lipid phosphatidyli-
nositol-4,5-bisphosphate (PI(4,5)P2) (Cai et al, 2008; Goni et al,
2014). PI(4,5)P2 levels are upregulated in focal adhesions by the PI
(4)P-5-kinase type Ic (Di Paolo et al, 2002; Ling et al, 2002), and we
previously reported that interactions with PI(4,5)P2 guide FAK
through a multistep activation sequence (Goni et al, 2014). This
involves PI(4,5)P2 binding via a basic patch on the FERM domain,
which induces FAK oligomerization and conformational changes
that trigger autophosphorylation of Y397 in the linker between the
FERM and the kinase domains. Subsequently, the Src kinase is
recruited via its SH2 and SH3 domains that interact with the
autophosphorylated linker in FAK and Src then phosphorylates resi-
dues Y576 and Y577 in the activation loop of the FAK kinase to
induce full catalytic activity (Calalb et al, 1995; Lietha et al, 2007).
Although previous work defined the main steps required for inte-
grin-mediated FAK activation (Goni et al, 2014), it did not provide a
structural understanding of events occurring on the membrane.
Here, we employ cryo-electron microscopy (cryo-EM) of FAK
bound to a PI(4,5)P2 membrane to provide structural details of
membrane-induced conformational changes and FAK oligomeriza-
tion. We observe that the oligomeric FAK assembly is formed via a
tightly packed symmetric FAK dimer and these dimers are linked
into an oligomer via FERM–FERM interactions that have previously
been observed for FAK in solution (Brami-Cherrier et al, 2014). Our
structure suggests a membrane-induced release of autoinhibition by
binding of FERM-mediated FAK dimers to PI(4,5)P2 via the basic
patch in the FERM domain. Intriguingly, the released kinase domain
reorients via a large conformational change placing the active site
toward the membrane. As a result, the linker is exposed to promote
efficient autophosphorylation. We show that interfaces observed in
the cryo-EM structure are important for cellular functions of FAK,
including cell proliferation in 3D and cancer cell invasion.
Results
Cryo-EM and overall architecture of FAK bound to a
PI(4,5)P2 membrane
For structural studies of membrane-bound FAK, we assembled puri-
fied FAK containing the FERM and kinase domains (FAK31-686) on
a lipid monolayer containing PI(4,5)P2 and analyzed samples by
cryo-EM. We showed previously that C-terminal regions required
for FAT do not affect PI(4,5)P2 binding, oligomerization, or PI(4,5)
P2-induced autophosphorylation (Goni et al, 2014). After sample
optimization, we obtained regular 2D crystal-like assemblies of FAK
(Fig 1B). We prepared samples in the absence (Apo) or presence of
the ATP analog AMP-PNP, the latter in order to mimic an ATP-
bound state and rigidify relative movements between the N-terminal
(N) and C-terminal (C) lobes of the kinase domain. We collected
cryo-EM datasets at different tilt angles for the Apo (0–60°) and
AMP-PNP bound state (0–50°). Crystallographic data processing
using 2dx (Gipson et al, 2007) resulted in low-resolution 3D maps
with a resolution of ~ 20 Å (Fig EV1A). To improve the resolution,
we next followed a single-particle analysis procedure by extraction
of particles from 2D crystal images (Righetto et al, 2019). A
summary of cryo-EM data collection and image processing parame-
ters is shown in Table EV1. The particle exhibits a twofold symme-
try and resulting 3D maps have an overall resolution of 6.32 Å
(Apo) or 5.96 Å (AMP-PNP; Fig EV1B), with local maximal resolu-
tion reaching ~ 4 Å (Fig 1C). We note that 2D crystals from the
AMP-PNP dataset could be classified into two different crystal pack-
ings as apparent from 2D classifications (Fig EV1C). Atomic models
were generated by flexible fitting of the crystal structures of the
FERM (PDB: 2AEH) and kinase domains of FAK (PDB:1MP8) into
the cryo-EM maps followed by manual adjustments (Figs 1D and
EV1D, Table EV2). Secondary structure elements are well defined,
but side chains rarely visible with a few exceptions (Fig EV1E). An
important consideration during model building was the position and
connectivity of the linker residues connecting the FERM and kinase
domains (residues 362–411). For this, density of a twofold symmet-
ric FAK dimer (hereafter referred to as symmetric dimer) at the
center of the AMP-PNP containing particle (zoomed in Fig 1D) was
inspected, since maps are best defined in this region. Residues 362–
394 are likely disordered and are not included in the model. Resi-
dues 395–401 (including the Y397 autophosphorylation site) are
modeled in the apo and AMP-PNP structures bound to the FERM F1
lobe, analogous to the position seen in autoinhibited FAK and
FERM-linker crystal structures (Ceccarelli et al, 2006; Lietha et al,
2007), based on density present at this position (Fig EV1F). Resi-
dues 402–411, leading to the kinase domain, are only modeled in
the AMP-PNP structure based on existing density, which is however
not continuous (Fig EV1G). Although we consider less likely, we
cannot exclude the possibility that residues 402–411 are disordered
and connect to the other kinase domain in the dimer. Importantly,
the main conclusions we draw apply with either connectivity. The
final Apo and AMP-PNP models are similar with an RMSD of 1.85 Å
comparing FAK monomers (superimposing 593 Ca atoms) or 2.23 Å
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Figure 1. Cryo-EM structure of the FERM-kinase region of FAK on a PI(4,5)P2 membrane.
A Domain structure of FAK. Important phosphorylation sites are indicated, and the FAK region used in the cryo-EM study is boxed with a dashed line.
B Negative stain image of 2D crystals containing the FERM-kinase region of FAK bound to a PI(4,5)P2 monolayer. Top right insert: Fourier transform of the 2D crystal
image. Bottom right insert: 2.5× zoom of the main image.
C Local resolution map of the refined Apo and AMP-PNP particle, as calculated with Blocres.
D 14 FAK molecules, each containing a FERM and kinase domain, are fitted into the EM maps obtained from the AMP-PNP dataset. Each molecule is in a different
color. Middle: Membrane distal view; right: Membrane proximal view; left: zoomed view of central symmetric dimer from the membrane distal view with locations of
FERM (F) and kinase (K) domains indicated. The equivalent figure for the Apo structure is shown in Fig EV1D.
E Linear oligomeric assembly of FAK formed by three symmetric FAK dimers in the AMP-PNP particle shown from the membrane distal view. FERM (F) and Kinase (K)
domains are labeled. FERM and kinase of the same molecule are in the same color with the kinases shaded in a lighter tone.
F Model of the FAK oligomeric assembly placed on a lipid bilayer. The membrane is placed by considering the KAKTLRK basic sequence in the FERM F2 lobe as main
membrane-binding site (Cai et al, 2008; Goni et al, 2014).
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superimposing the symmetric FAK dimer (1,186 Ca atoms). Below,
we describe the FAK-AMP-PNP structure unless stated otherwise.
The final structure contains 14 FAK molecules, each of them
assembles into closely associated symmetric FAK dimers (Fig 1D).
The symmetric dimers connect via FERM–FERM contacts to neigh-
boring dimers to form a linear oligomeric assembly (Fig 1E). Lateral
contacts to this linear oligomer are likely introduced crystallographi-
cally since they differ in the two crystal forms seen in the AMP-PNP
dataset (Fig EV1C), whereas the linear arrangement shown in
Fig 1E is present in all crystals (AMP-PNP and Apo). To model the
FAK structure on the lipid membrane (which is for the most part not
visible in 3D averaged maps), we considered the reported
K216AKTLRK motif on the FERM domain as primary PI(4,5)P2-
binding site (Cai et al, 2008; Goni et al, 2014). As seen in Fig EV2A,
this sequence aligns in all 14 FAK molecules in one plane allowing
confident positioning of the lipid membrane relative to the FAK
oligomer (Fig 1F). In further support of membrane placement, 3D
maps show unmodeled density at the KAKTLRK motif, as well as at
sites where the kinase domain contacts the modeled membrane
(Fig EV2B), likely due to less mobile lipid molecules interacting
with FAK at these sites.
FAK oligomerizes on the membrane via multiple interfaces
The resulting structural assembly reveals several new interfaces as
well as interactions observed previously. Within the symmetric FAK
dimer, new interactions are formed intramolecularly between the
FERM and kinase domains (F–K and F’-K’ in Fig 2A) and inter-
molecularly between FERM and kinase domains (F–K’ and F’-K) as
well as between two kinase domains (K–K’). Bridging dimers into
an oligomeric assembly occurs via FERM–FERM interactions (F–F*
and F0–F** in Fig 2A) in a manner described previously to occur for
FAK in solution (Brami-Cherrier et al, 2014). This interface involves
W266 and is seen in 3D crystal structures that contain the FAK
FERM domain. Superposition of this crystallographic FERM dimer
with FERM domains in our cryo-EM structure shows a highly similar
FERM–FERM interaction (Fig 2B). For newly observed interactions
within the symmetric dimer, EM maps provide limited details since
sidechains are mostly not defined. We therefore performed Molecu-
lar Dynamics (MD) simulations on the symmetric FAK dimer to
orient sidechains for nearby interactions, while the FAK backbone
was restrained by EM maps. Analysis of the interactions throughout
the simulations with PISA (Krissinel & Henrick, 2007) and SC
(Lawrence & Colman, 1993) reveals rather extensive interactions of
predominantly polar (intramolecular F–K), mixed (intermolecular
F–K0), or hydrophobic (intermolecular K–K’) character and signifi-
cant shape complementarity (Table 1; Fig 3A–C), with highest
energy gain suggested to result from the K–K’ interaction. In addi-
tion to protein–protein interfaces, we also observe contacts with the
modeled membrane, other than the KAKTLRK sequence in the
FERM domain used for membrane positioning. The kinase domain
is positioned lying flat on the membrane with main contacts made
via the basic residues K621 and K627 in the kinase C-lobe (Fig 3D).
In this conformation, the active site of the kinase domain is facing
toward the membrane. Inspection of the electrostatic potential of
the membrane-interacting surface of the symmetric FAK dimer
reveals in addition to the KAKTLRK basic patch a large basic region
on the kinase domain that includes K621 and K627 (Fig 3E). In
agreement with our structural findings, these residues have been
reported previously to contribute to PI(4,5)P2 binding in FAK (Hall
& Schaller, 2017).
We showed previously that PI(4,5)P2-mediated membrane bind-
ing of FAK promotes autophosphorylation (Goni et al, 2014). To test
whether autophosphorylation can occur in the observed membrane
bound conformation, we modeled the linker residues in the FAK
symmetric dimer to adopt a conformation as required for autophos-
phorylation, meaning that Y397 is located at the kinase active site
according to known substrate-kinase interactions (Hubbard, 1997).
Although the active site points toward the membrane, we found that
the linker can wrap around FAK such that Y397 is in an orientation
susceptive for autophosphorylation, without the need to move the
original position of the kinase domain from the cryo-EM structure
(Fig EV3A). The position of Y397 in the active site also remained
stable during MD simulations of a FAK dimer placed on a PI(4,5)P2-
containing membrane, suggesting that autophosphorylation in this
conformation is possible. Next, we compared the dynamics of this
autophosphorylation-ready FAK conformation to those observed in
simulations of FAK models in which Y397 is not bound to the active
site. We observed that the kinase domain moves closer to the
membrane in the simulations of unbound compared to bound Y397
(Fig EV3B) and that residues from the activation loop, most notably
K583, interact with lipid head groups thereby closing the active site
entry (Fig EV3D). When the FERM-kinase linker occupies this
space, residues adjacent to Y397 form stable interactions with the
same activation loop residues that otherwise interact with the
membrane (Fig EV3C and D). The interaction between linker
residue I400 and activation loop residue K583 remains stable in 11
out of 14 simulations or for 87% of the total simulation time
(Fig EV3E). These results indicate that the linker could displace acti-
vation loop-membrane interactions and in this way guide Y397 to
the active site.
FERM dimerization and membrane interactions are key for
FAK autophosphorylation
To test the relevance of the structural findings, we generated
mutants at the observed interfaces (Table 2). The mutations do not
appear to affect the protein integrity (Appendix Fig S1) and behave
like FAK wild type (WT) as a monodisperse particle with a hydrody-
namic radius compatible with a FAK monomer (Table EV3). We first
tested the effect of the mutations on PI(4,5)P2-induced autophos-
phorylation using an ELISA assay. As shown previously, autophos-
phorylation of FAK-WT is strongly enhanced in the presence of PI
(4,5)P2 containing vesicles (Goni et al, 2014) (Fig 4A), whereas
catalytic turnover activity toward an exogenous substrate is not
affected by PI(4,5)P2 (Fig 4B). The interface mutations do not affect
catalytic turnover activity to a major extent, whereas the F–F* and
both FAK–membrane interactions (KAKTLRK and Kinase-Mem-
brane) appear key to achieve high autophosphorylation rates
(Fig 4A). Overall mutations within the symmetric dimer have little
effect; however, mutation of hydrophobic residues at the K–K’ inter-
face causes a reproducible reduction in autophosphorylation effi-
ciency. We next asked whether autophosphorylation occurs in cis
(enzyme and substrate in the same molecule) or trans (enzyme and
substrate in different FAK molecules). For this, we incubated either
FAK-WT or a catalytically inactive kinase dead mutant (KD,
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contains the K454R mutation) in the presence of a catalytically
active, but substrate deficient Y397F mutant. Combining KD and
Y397F mutants exclusively allows autophosphorylation in trans,
while FAK-WT with Y397F can autophosphorylate in cis and trans
(see schematic in Fig 4C). We observe that in the absence of PI(4,5)
P2 the WT-Y397F combination autophosphorylates significantly
more efficiently, whereas the presence of PI(4,5)P2 renders the
WT-Y397 and KD-Y397F combinations to equal and strongly
increased autophosphorylation efficiency (Figs 4C and EV4A–B),
indicating that in solution autophosphorylation occurs mainly in cis,
but trans-autophosphorylation appears to be dominant in the pres-
ence of PI(4,5)P2. We note that the cis-autophosphorylation we
observe in solution could be caused by the absence of the C-term-









































Figure 2. Interfaces in the FAK oligomeric assembly on the membrane.
A Close-up of the central symmetric dimer of the AMP-PNP particle from the membrane distal view. Interfaces within the symmetric dimer are formed intramolecularly
between the FERM and kinase domains (F and K; F’ and K’). Intermolecular interfaces are formed within the symmetric dimer between F and K’, F’ and K as well as K
and K’. Intermolecular interactions that link symmetric dimers are formed between two FERM domains (F and F*; F’ and F**). Coloring is as in Fig 1E. The FERM
subdomains F1 and F3 (F2 is not visible from this view), kinase N- and C-lobes (KN, KC), AMP-PNP and the N- and C-termini (N, C) are labeled.
B Superposition of W266-mediated FERM–FERM 3D-crystallographic dimers (Ceccarelli et al, 2006) (yellow; PDB: 2AEH) and the FERM–FERM contacts seen in the cryo-
EM structure to link symmetric dimers (F–F*; F’–F**). The view is 90° rotated from panel (A). Subdomains and termini are labeled, and disordered regions in the linker
are shown as dashed line.
Table 1. FAK interfaces.




F–K 431  73 3.2  2.2 8.3  2.3 5.1  1.5 0.54  0.08
F–K’ 640  109 3.8  1.9 5.5  2.5 9.3  3.3 0.52  0.10
K–K’ 623  61 9.5  2.0 3.4  1.7 12.9  1.7 0.51  0.07
Interfaces: F–K: intramolecular FERM–kinase; F–K0: intermolecular FERM–kinase; K-K0 : intermolecular kinase–kinase.
aCalculated by PISA (Krissinel & Henrick, 2007).
bShape complementarity, calculated by SC (Lawrence & Colman, 1993).
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for trans-autophosphorylation also in solution (Brami-Cherrier et al,
2014). However, C-terminal regions are shown not to affect
membrane-associated autophosphorylation (Goni et al, 2014), likely
because the FAT domain is released from the KAKTLRK region upon
membrane binding of the FERM domain.
We next examined the effect membrane binding of FAK has on
activation loop phosphorylation by Src, using an ELISA assay to
monitor Y577 phosphorylation of FAK in the presence of Src. Using
only the Src kinase domain PI(4,5)P2 does not enhance Src phos-
phorylation of FAK-WT while the open and activated Y180A,
M183A mutant of FAK exhibits significantly reduced Src phosphory-
lation in the presence of PI(4,5)P2 (Fig 4D). On the other hand,
when using a longer Src construct that can interact with
autophosphorylated FAK (SH3-SH2-kinase) Src phosphorylation effi-
ciency of WT-FAK increases in the presence of PI(4,5)P2 (likely due
to enhanced FAK autophosphorylation), however to a significantly
lower extent than is seen for FAK autophosphorylation. Results
using only the Src kinase domain agree with structural observations
showing that the FAK active site and nearby activation loop are not
exposed in the membrane bound state (Fig 3D).
We further tested how the mutations affect binding to PI(4,5)P2
membranes. As expected, mutations at membrane interaction sites
are deficient in PI(4,5)P2 binding, with KAKTLRK mutations in the
FERM domain resulting in somewhat lower residual binding than
mutation in the Kinase C-lobe (Fig 5). Surprisingly, mutation of the











































Figure 3. Key interactions at interfaces.
A–C Details of intramolecular F–K (A) and intermolecular F–K’ (B) and K–K’ (C) interactions as seen in simulations restrained by EM maps. Side chains of main
interacting residues are shown in stick representation, and hydrogen bonds are shown as orange dashed lines.
D The kinase is oriented with the ATP-binding site facing the membrane. Key interactions between the kinase and the membrane are made by K621 and K627. The
side chains of K621, K627, and K216 (the latter is within the KAKTLRK motif of a neighboring FERM domain) as well as AMP-PNP bound to the ATP-binding site are
shown in stick representation.
E Electrostatic surface potential of the symmetric FAK dimer as seen from the membrane proximal view. Both, the FERM (KAKTLRK) and the kinase (K621, K627) have
extensive positive charges on this surface for interaction with negatively charged PI(4,5)P2 lipids. The kinase domains are encircled by a yellow dotted line.
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is likely due to loss of avidity since our structural data indicate that
the mutated W266 affects intermolecular F–F* interactions, but is
distant to the membrane. Further, mutation of hydrophobic residues
at the K–K’ interface modestly reduce PI(4,5)P2 binding. Taken
together, mutational effects on PI(4,5)P2 binding closely mirror
effects on PI(4,5)P2-induced autophosphorylation (Fig 4A).
FERM dimerization and PI(4,5)P2 binding are together essential
for cellular FAK activation and cancer cell invasion
To test the importance of the observed interfaces in cells, we intro-
duced FAK mutants that affected autophosphorylation and binding
to PI(4,5)P2 vesicles into FAK-deficient squamous cell carcinoma
(SCC) cells, in which the gene encoding fak was deleted by Cre-
mediated recombination (McLean et al, 2004). As observed with
purified proteins, the most severe effects are caused by mutations at
FAK-membrane (KAKTLRK and Mut-KM) and F–F* interfaces,
resulting in strongly reduced FAK autophosphorylation on Y397 and
other tyrosine phosphorylation sites, including Y576/Y577 and Y925
(Fig 6A). We note that the KM mutations cause reduced steady state
levels of FAK, complicating quantifications for some of the phospho-
rylation sites. In these SCC cells, FAK appears upstream of Src, since
the mutations can also cause reduced Src phosphorylation on Y416,
a surrogate of the Src activation state (Fig 6B). On the other hand,
mutation at the symmetric K–K’ dimer interface does not lead to
detectable changes in FAK or Src phosphorylation, but effects
appear amplified downstream at the level of Akt and ERK phospho-
rylation (Fig 6B). Remarkably, combining mutations at the F–F*
and K–M interfaces has an additive effect and leads to a complete
loss of FAK-Src association (Fig 6C).
We next analyzed the effect of the mutations on FAK and Src
localization and intracellular trafficking. The FAK mutants still
localize to focal adhesions as visualized by confocal microscopy
(Fig 7A); however, phosphorylated Src is internalized in cells
expressing the FERM-membrane and F–F* interface mutants and
targeted into puncta that we have identified previously as
autophagosomes (Sandilands et al, 2011) (Fig 7B). This is indicative
of defective FAK signaling at focal adhesions as a result of partners
of FAK, in this case p-Src, not being properly tethered into protein
complexes at focal adhesions, likely due to impaired scaffolding
functions or positioning. The removal of p-Src to the autophagy
pathway under such circumstances signifies that FAK is dysfunc-
tional (Sandilands et al, 2011). Furthermore, of the tested interface
mutants only the KAKTLRK FERM-membrane mutant reduces
nuclear localization of FAK (Fig 7C), likely due to a nuclear localiza-
tion sequence within the KAKTLRK sequence (Lim et al, 2008),
implying nuclear translocation is not perturbed by altering the FAK
assembly on the membrane.
We further analyzed the effect of FAK mutants on SCC cell prolif-
eration in 3D cultures and invasion through Matrigels. All tested
interface mutants exhibit a significant reduction in cell proliferation
in 3D cultures (Fig 8A). This is in contrast to SCC cell invasion,
where mutation of the K–K’ interface has no effect, however,
combining mutations at membrane and F–F* interaction sites
severely hampers invasion, while mutation of the kinase–membrane
interface alone enhances invasion by a mechanism that is unknown
(Fig 8B). Therefore, our mutational data in SCC cells demonstrate
that different interfaces observed in the EM structure differentially
affect specific cellular FAK functions. On the one hand, FERM and
kinase interactions with the membrane as well as FERM dimeriza-
tion via the F–F* interface are crucial for FAK signaling, FAK/Src
dynamics, cell proliferation, and invasive migration. On the other
hand, FAK oligomerization via the K–K’ interface has more subtle
effects with mutations causing impaired downstream signals at the
level of MAP and Akt kinases, likely contributing to suboptimal
FAK-mediated cancer cell proliferation under anchorage-indepen-
dent condition. The strong effects in SCC cells seen with membrane
and F–F* interaction mutants, but subtle changes caused by K–K’
mutations agree well with data obtained with purified mutants
(Figs 4A and 5).
Discussion
Focal adhesion kinase constitutes an important element in the
complex multilayered architecture of focal adhesions and localizes
into the most membrane proximal layer in cells (Kanchanawong
et al, 2010). The membrane at focal adhesion sites has increased
levels of PI(4,5)P2 (Di Paolo et al, 2002; Ling et al, 2002) and our
new structural insights provide a detailed view of how FAK spon-
taneously assembles on a membrane containing PI(4,5)P2. Impor-
tantly, the cellular data presented here (Figs 6–8) as well as
reported previously (Cai et al, 2008; Brami-Cherrier et al, 2014;
Hall & Schaller, 2017) support that our cryo-EM structure repre-
sents a state that is important for FAK to convert into an active
signaling kinase in focal adhesions. In cells, FAK is known to
undergo large conformational changes when integrated into focal
adhesions (Cai et al, 2008) and the cryo-EM structure presented
here provides the structural basis for this change. Superposition of
the autoinhibited FERM-kinase structure of FAK (Lietha et al,
2007) with the FERM domain in our membrane-bound structure
shows a large movement of the kinase domain (~ 80 Å at the C-
terminus) and a rotation of ~ 90°, approximately around the
kinase N-terminus (Fig 9A). Our structure also immediately
suggests a mechanism that is responsible for triggering the confor-
mational change. When visualizing the above superposition in the
presence of the membrane, it is apparent that the kinase in the
Table 2. Interface mutants.
Name Mutations Mutated interface
Mut-FK Q418A, E420A, R421A, E492A,
N493A
F–K
Mut-FK0 E683A, Q686A F–K0
Mut-KK0 A448D, M449A, A450D K–K0
Mut-FF* W266A F–F*
Mut-PPi Q418A, E420A, R421A, E492A,




(F–K, F–K0 , K–K0 , F–F*)
KAKTLRK K216A, K218A, R221A, K222A F–M
Mut-KM K621A, K627A K–M
Mut-FF*/KM W266A, K621A, K627A F–F* and K–M
Interfaces: F–K: intramolecular FERM–kinase; F–K0: intermolecular FERM–
kinase; K–K0 : intermolecular kinase–kinase; F–F*: intermolecular FERM–FERM;
F–M: FERM–membrane; K–M: Kinase–Membrane.
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autoinhibited conformation would cause a significant steric clash
with the membrane (Fig 9B). This clash occurs as F–F*-mediated
FAK dimers approach and bind the membrane via their KAKTLRK
lipid-binding sites. Hence, formation of a F–F*-mediated dimer is
essential to trigger the conformational change in agreement with






























































































































































Figure 4. In vitro phosphorylation and catalytic activity of interaction mutants.
A Autophosphorylation as measured in an ELISA assay is shown for WT and interaction mutants in the presence of control vesicles (PC; phosphatidylcholine) or PI(4,5)
P2 containing vesicles. Plotted are mean values from two independent autophosphorylation reactions, each determined in duplicates (n = 4). Mutant nomenclature is
as shown in Table 2.
B Catalytic turnover activity as measured in a coupled kinase assay is shown. Plotted are mean values from at least three independent experiments.
C To determine whether autophosphorylation occurs in cis or trans, autophosphorylation was measured for WT or a kinase dead form of FAK (KD, contains K454R
mutation) in the presence or absence of a substrate deficient FAK mutant (Y397F) and/or PI(4,5)P2 vesicles. PI(4,5)P2 negative experiments contain control PC vesicles
instead. Note that the scales of the two plots are different, i.e., autophosphorylation is increased in the presence of PI(4,5)P2. Plotted are mean values from two
independent phosphorylation reactions, each determined in duplicates (n = 4). Left: Schematic of possible cis- and trans-autophosphorylation (red arrows) in
mixtures of FAK-WT/FAK-Y397F and FAK-KD/FAK-Y397F. See also Fig EV4A and B for experiments at different protein concentrations and time points.
D Src phosphorylation of Y577 in FAK in the presence of PC or PI(4,5)P2 vesicles as determined by an ELISA method. The plot on the left is obtained in the presence of
Src containing only the kinase domain (Src254-536) and the plot on the right with Src containing additionally the SH3 and SH2 domains (Src84-536). Plotted are
mean values from two independent phosphorylation reactions, each determined in duplicates (n = 4).
Data information: (A–D) error bars: s.d.
Source data are available online for this figure.
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induced FAK autophosphorylation and cellular function (Brami-
Cherrier et al, 2014) (Figs 4A and 6–8). We present a model
where membrane-induced release of FAK autoinhibition in a F–F*-
mediated FAK dimer represents a first and essential step in a
multistep activation sequence of FAK (Fig 9C). It is interesting to
note that PI(4,5)P2 binds and induces functionally important
conformational changes in other FERM containing proteins, includ-
ing in ERM proteins, talin, and merlin. However, surprisingly the
PI(4,5)P2-binding site is not conserved in these FERM domains
(Hamada et al, 2000; Saltel et al, 2009; Moore et al, 2012;
Chinthalapudi et al, 2018).
Once the kinase domain of FAK is released from the FERM
domain, it is free to rearrange. As one would expect, the kinase then
rotates with its own basic patch containing K621 and K627 toward
the membrane. This requires an approximately 90° rotation of the
kinase, which if rotated around the kinase N-terminus brings the
kinase into a position very close to the one observed in the cryo-EM
structure (Fig EV5). Kinase rearrangement and membrane interac-
tion via K621 and K627 are an essential second step in the FAK acti-
vation sequence (Fig 9C), as demonstrated by mutations at the
kinase–membrane interface (Hall & Schaller, 2017) (Figs 4–8).
Indeed, it appears that kinase–membrane interactions are required
to keep FAK stably on the membrane and hence prevent reformation
of the autoinhibited FERM-kinase conformation, as mutation of
K621 and K627 results in significantly reduced binding to PI(4,5)P2
membranes (Hall & Schaller, 2017) (Fig 5). A similar kinase–
membrane interaction was observed in one of two possible
membrane-binding modes seen in coarse grain MD simulations of
FAK on a PI(4,5)P2 membrane (Herzog et al, 2017). However, in


























































Figure 5. PI(4,5)P2 binding.
Interactions between WT or interface mutant FAK with a PI(4,5)P2 containing membrane was probed using a pull-down assay with membrane coated silica beads. Plotted
are bound protein relative to the binding forWT at the highest PI(4,5)P2 concentration. Mutant naming is as in Table 2. ForWT, the non-specific binding to a PCmembrane is
shown for comparison. Plotted are mean values from at least three independent experiments. Error bars: s.d.
Source data are available online for this figure.
▸Figure 6. FAK signaling in SCC cells.A FAK phosphorylation of WT or interface mutant FAK in SCC cells. Whole cell lysates were subjected to Western blot analysis with anti-pFAK Y397, anti-pFAK Y576/577,
anti-pFAK Y861, anti-pFAK Y925, and anti-FAK. Anti-GAPDH served as a loading control. The graph shows densitometric analysis of relative pFAK/FAK ratios (mean)
from three independent experiments. Student’s t-test was carried out to calculate the statistical significance. Error bars: s.d. *P < 0.01, #P < 0.05. For full blots see
source data.
B Downstream signaling in SCC cells expressing WT or interface mutant FAK. Whole cell lysates are analyzed by Western blot analysis with the indicated antibodies.
The graph shows densitometric analysis of relative phospho/total protein ratios (mean) from three independent experiments. Student’s t-test was carried out to
calculate the statistical significance. Error bars: s.d. *P < 0.01, #P < 0.05. For full blots see source data.
C Src phosphorylation and interactions between FAK and Src or pSrc Y416 in SCC cells. FAK, Src or pSrc Y416 were immunoprecipitated from whole cell SCC lysates
using anti-pSrc Y416, anti-FAK, anti-Src, or non-specific IgG-agarose, followed by Western blot analysis with anti-FAK, anti-pSrc Y416, and anti-Src. Anti-GAPDH
served as a loading control. For full blots, see source data.
Source data are available online for this figure.
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remained intact and as a consequence the two basic patches on
FERM and kinase domains are not able to form ideal membrane
interactions simultaneously. Together, kinase release from the
FERM domain and subsequent attachment to the membrane keep
the kinase in a position that expose the Y397 site for efficient
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M183A mutant (Lietha et al, 2007; Goni et al, 2014) (Fig 4A).
Combining mutations that prevent both of the two-first steps (Mut-
FF*/KM) is detrimental to any cellular activity we tested (Figs 6–8).
Once FAK interacts with the membrane via FERM and kinase
domains a large surface of ~ 1,200 A2 over both domains aligns for
association of the symmetric dimer via F–K’, K–K’, and K-F’ inter-
faces, resulting in formation of FAK oligomers (step 3 in Fig 9C).
Our data suggest that FAK autophosphorylation on the membrane
occurs in trans (Figs 4C, and EV4A and B), likely within the symmet-
ric dimer, which has the active site of one molecule within 42 Å of
Y397 bound to the FERM domain in the other molecule. This distance
would be 57 Å for cis-autophosphorylation and 105 Å for trans-autop-
hosphorylation across a F–F*-mediated dimer, which even the
released linker cannot reach. Notably, K–K’ mutations have relatively
subtle effects, possibly because a partially intact interface is sufficient
for formation of a transient enzyme–substrate complex. Nevertheless,
K–K’ mutations consistently affect FAK function in vitro and in cells
(Figs 4A, 5, 6B and 8A). Interestingly, K-K mutations affect 3D cell
proliferation but not invasion. As shown in other signaling systems,
different signaling levels can control different biological outputs
(Benschop et al, 1999; Zhou et al, 2014; Gottschalk et al, 2016). It is
possible that reduced FAK oligomerization by disruption of the K–K’
interface lowers signaling levels below a threshold required for effi-
cient cell proliferation, but is still sufficient for cell invasion (Fig 8).
Surprisingly, the kinase–membrane interface mutant exhibits substan-
tially increased cell invasion capability in our assay. The reason for
this is unclear, but an intriguing speculation would be that in the
setting of this experiment this mutant can still enter the activation
sequence shown in Fig 9C, but due to failure of the kinase domain to
interact with the membrane the active site is exposed, causing
increased kinase activation and SCC invasion.
It is indeed a key observation in our cryo-EM structure that the
active site of the FAK kinase domain is not exposed in the
membrane bound state. We believe this explains why the turnover
activity toward an exogenous substrate is not increased by binding
to PI(4,5)2 (Goni et al, 2014) (Fig 4B), even though autoinhibitory
FERM-kinase interactions are released. This raises the question of
the relevance of keeping FAK activity low upon PI(4,5)P2 binding.
Our hypothesis is that the membrane bound state we observe repre-
sents an additional layer of regulation, where PI(4,5)P2-binding
primes FAK for activation, but an additional event is required to
trigger catalytic activity. Full activity requires phosphorylation of
the activation loop residues Y576 and Y577 by Src (step 4 in Fig 9C)
(Calalb et al, 1995; Lietha et al, 2007), yet these sites, being close to
the active site, are still occluded by kinase–membrane interactions
and membrane binding inefficiently enhances their phosphorylation
(Fig 4D). In our in vitro system, increased recruitment of Src
containing SH2 and SH3 domains to autophosphorylated FAK is suf-
ficient to boost Src phosphorylation of Y576/Y577 in the presence of
PI(4,5)P2 to some extent. However, it is tempting to speculate that
in the crowded environment of the cell an additional stimulus could
be required to expose the FAK active site and activation loop to trig-
ger full FAK activity. Several triggers might exist and could be
important physiologically depending on the cellular context. One
stimulus that structurally seems plausible is the generation of
tension force that builds up upon contraction of actomyosin fibers
that are attached to focal adhesions. Stretching of the FAK molecule
via FERM attachment to the membrane and C-terminal cytoskeletal
anchoring could expose the FAK active site for activation, as shown
by single molecule force spectroscopy (Bauer et al, 2019). Further,
FAK is activated in cells with increasing tension at focal adhesions
(Torsoni et al, 2003; Wong et al, 2011; Seong et al, 2013) and FAK
can act as a cellular force sensor that is required for cellular outputs
in response to force (Wang et al, 2001). The structural assembly we
observe of FAK on the membrane is fully compatible with a scenario
where force applied to FAK via C-terminal attachment to cytoskele-
tal components could be responsible for detachment of the kinase
domain from membrane and FERM interactions to expose the active
site and nearby activation loop to induce activation.
In conclusion, we present new structural information of an oligo-
meric membrane bound state of FAK, providing atomic details on a
key component of the signaling layer in focal adhesions. The struc-
ture demonstrates that FAK undergoes large domain rearrangements
upon membrane binding and suggests membrane binding as a
◀ Figure 7. FAK and Src localization in SCC cells expressing interface mutant FAK.A, B FAK-expressing SCC cells were grown on glass coverslips, fixed, and stained with anti-FAK (A), or anti-pSrc Y416 (B), anti-Paxillin and DAPI (A, B). Representative
immunofluorescence images are shown. Scale bars, 20 lm. The graph (B) shows the quantification of internalized active Src from three independent experiments.
Student’s t-test was carried out to calculate the statistical significance. Error bars, s.d. *P < 0.01.
C Subcellular fractionation of SCC cells expressing FAK-WT or interface mutant FAK. Whole cell lysates (WCL) and subcellular fractions were subjected to Western blot
analysis with anti-FAK, anti-Tubulin (marker for cytoplasmic fraction; C), anti-RCAS (marker for perinuclear fraction; PN), and anti-H4 (marker for nuclear fraction;
N). The graph shows densitometric analysis of relative FAK amount of the FAK mutants in the different fractions from three independent experiments. Student’s
t-test was carried out to calculate the statistical significance. Error bars: s.d. *P < 0.01, #P < 0.05. For full blots see source data.
Source data are available online for this figure.
▸Figure 8. FAK mutant SCC cells in 3D proliferation and invasion.A FAK-WT, interface mutant FAK or FAK/ SCC cells were resuspended in methylcellulose solution in growth medium on a layer of agarose and observed for 3D sphere
formation. Images were taken from 10 random fields after 9 days (representative images are shown) and the relative colony size (top graph) and the number of
colonies (bottom graph) were assessed from three independent experiments. Scale bars, 200 lm. Student’s t-test was carried out to calculate the statistical
significance. Error bars s.d. *P < 0.01, #P < 0.05.
B FAK-WT, interface mutant FAK or FAK -/- SCC cells were seeded on growth factor-reduced Matrigel in serum-free media. After 72 h, invasion toward a serum gradient
was analyzed by staining the cells with calcein and taking images at 10 lm increments through the Matrigel. Representative images of the invasion assay are shown.
Scale bars, 200 lm. The graph shows relative invasion from five independent experiments. Student’s t-test was carried out to calculate the statistical significance.
Error bars, s.e.m. *P < 0.01, #P < 0.05.
12 of 21 The EMBO Journal e104743 | 2020 ª 2020 The Authors
The EMBO Journal Iván Acebrón et al
trigger that releases autoinhibition. A surprising feature in the struc-
ture is that the kinase active site is facing toward the membrane and
we propose that this represents a primed state of FAK that requires
an additional trigger for full catalytic activation. Whereas dimeriza-
tion and kinase attachment to the membrane are essential for any
biological activity, stable oligomerization further increases the
A B
Figure 8.
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signaling level above a threshold required for cell proliferation.
These insights could help in the design of novel agents targeting
either all or specific functions of FAK.
Materials and Methods
Protein expression and purification
Focal adhesion kinase-WT and mutants were expressed and purified
as described earlier (Goni et al, 2014). In brief, FAK from Gallus
gallus that contains the FERM and the kinase domains (chFAK31-
686) was expressed in HEK293GnT1 cells by transfecting the pOPIN-
F vector (Berrow et al, 2007) containing the chFAK31-686 sequence
with a N-terminal 6xHis tag using polyethyleneimine (PEI) as a
carrier. Cells were harvested, lysed, and purified by Ni-affinity chro-
matography (HisTrap column, GE Healthcare), ionic exchange chro-
matography (Source15Q, GE Healthcare), and size exclusion
chromatography (Superdex200, GE Healthcare). The poly-His tag
was removed by cleavage with 3C PreScission protease. Recombi-
nant human Src proteins containing either only the kinase domain
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Figure 9. Membrane-induced FAK activation.
A FERM superposition of autoinhibited FAK (Lietha et al, 2007) (yellow, PDB: 2J0J) with a membrane bound FAK monomer as observed in the cryo-EM structure (green)
shown from the membrane proximal view. The KAKTLRK membrane-binding site on the FERM domain is colored red and membrane interacting residues K621 and
K627 in the kinase domain are in cyan with side chains in space fill representation.
B FERM superpositions of autoinhibited FAK (yellow) with a F–F*-interacting FERM dimer bound via the KAKTLRK motifs (red) to a lipid membrane. Membrane-bound
kinase domains connected to the FERM domains F and F* are removed for clarity.
C Schematic model for PI(4,5)P2 induced FAK activation in focal adhesions. Locally increased concentrations of FAK upon focal adhesion targeting promotes formation
of FERM mediated FAK dimers. Binding of FAK dimers via their KAKTLRK basic region (dark blue) to PI(4,5)P2-rich membranes in focal adhesions causes dissociation of
the autoinhibitory interaction between the FERM and Kinase (KIN) domains (step 1). The released kinase domains reorient to interact via their own basic residues
with the membrane (step 2). This aligns a large surface (F–K’, K–K’, and F’–K in Fig 2A) for formation of the symmetric dimer and exposes the autophosphorylation site
for efficient trans-autophosphorylation across the symmetric dimer (step 3). Src is recruited to the autophosphorylation site and phosphorylates Y576 and Y577 in the
activation loop (A-loop) of FAK to induce catalytic activation of FAK (step 4). Possibly an additional mechanism is involved in removing the kinase domain from the
membrane to expose the Src phosphorylation sites, thereby potentiating the activating step 4 (see text).
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with an N-terminal 6xHis tag were expressed in Escherichia coli
BL21(DE3) by coexpression with YopH as reported by Seeliger et al
(2005). Pure protein was obtained by Ni-chelate affinity chromatog-
raphy (HisTrap), ion exchange chromatography (Source 15Q), and
size exclusion chromatography (Superdex200). After the Ni-
chelating column, the 6xHis tag was removed by incubation with
TEV protease.
Generation and optimization of FAK 2D crystals
For 2D crystallization, lipid monolayers were obtained by adding a
1:1 mixture of unsaturated porcine brain PI(4,5)P2 (Avanti Polar
Lipids) with saturated PI(4,5)P2diC16 (Echelon Biosciences) to a
well containing FAK31-686 at 0.05 mg/ml in 300 mM lithium
sulfate, 50 mM sodium acetate pH 5.5, and 1 mM TCEP. Two-
dimensional crystals were formed over 5–7 days at 4°C. For initial
crystal evaluation FAK 2D crystals, samples were negatively stained
on carbon coated grids with 2% uranyl acetate and imaged using a
120 kV Tecnai G2 Spirit electron microscope, equipped with the
TVIPS CMOS detector. AMP-PNP containing crystals were obtained
as for Apo crystals, but adding 1 mM AMP-PNP and 2 mM MgCl2.
Cryo-EM data collection
Apo dataset
Grids containing vitrified 2D crystals of apo-FAK were imaged using
both a Titan Krios (Thermo Fischer Scientific) transmission electron
microscope (TEM) operating at 300 kV equipped with a Gatan
Quantum-LS energy filter (slit width 20 eV; Gatan Inc.) and a K2
Summit direct electron detector (Gatan Inc.), and a Tecnai G2 Polara
(Thermo Fischer Scientific) TEM operating at 300 kV also equipped
with a K2 Summit direct electron detector, without energy filter. In
both microscopes, SerialEM (Mastronarde, 2005) was used for auto-
mated data collection at each tilt angle, which was manually varied
from 0 to 60 degrees in steps of 15 degrees. Movies were recorded at
the Titan in super-resolution mode with a physical pixel size at the
sample level of 1.058 Å/px (0.529 Å/px in super-resolution), and at
the Polara in counting mode with a pixel size at the sample of level
1.7 Å/px. Each of the 515 movies from the Titan dataset comprised
an exposure of 40 e-/Å² fractionated into 80 frames over 10 s. For
the Polara dataset, each of the 97 movies acquired comprised an
exposure of 40 e-/Å² fractionated into 50 frames over 10 s. Movie
frames were aligned for drift correction and averaged with dose-
weighting using MotionCor2 (Zheng et al, 2017), with down-
sampling to the physical pixel size in the case of the Titan dataset.
Defocus measurement was carried out using CTFFIND4 (Rohou &
Grigorieff, 2015) and CTFTILT (Mindell & Grigorieff, 2003) to esti-
mate the tilt geometry via 2dx (Gipson et al, 2007).
AMP-PNP dataset
Grids containing vitrified 2D crystals of FAK in the presence of
AMP-PNP were imaged using a Titan Krios TEM operating at
300 kV equipped with a Gatan Quantum-LS energy filter (slit width
20 eV) and a K2 Summit direct electron detector. SerialEM was
used for automated data collection at each tilt angle, which was
manually varied from 0 to 50 degrees in steps of 10 degrees. A
total of 2,608 movies were recorded in super-resolution mode at
the Titan with a physical pixel size at the sample level of
1.058 Å/px (0.529 Å/px in super-resolution). Each movie from the
Titan dataset comprised an exposure of 80 e-/Å² fractionated into
40 frames over 8 s. The acquired data were pre-processed in real
time using FOCUS (Biyani et al, 2017). Super-resolution movie
frames were aligned for drift correction, downsampled to the phys-
ical pixel size, and averaged with dose-weighting using
MotionCor2. Defocus measurement was carried out using
CTFFIND4 and CTFTILT to estimate the tilt geometry.
3D reconstruction
Apo dataset
Initial 2D crystal structure determination was carried out in 2dx
following conventional electron crystallography protocols, revealing
unit cell parameters of a = 110 Å, b = 88 Å and c = 107°. The FAK
2D crystals were found to be highly disordered, with no visible
diffraction spots beyond ~ 20 Å in the non-tilted images. Conse-
quently, a low-resolution electron potential map with p2 symmetry
imposed resulted from this processing (Fig EV1A), after pruning
and merging data from 595 selected 2D crystal images, being 508
movies from the Titan and 87 from the Polara datasets. This map
allows placing of the FERM domain but shows weak density for the
kinase domain. Attempting a higher resolution reconstruction, we
then applied the single-particle approach to 2D crystals implemented
in the FOCUS package. Briefly, the approach consists of extracting
patches of the 2D crystal images and treating them as single parti-
cles, therefore allowing for local corrections of lattice distortions
(Righetto et al, 2019). We extracted 361,796 particles from the 595
images previously selected, using a box size of 238 × 238 pixels and
a pixel size of 1.7 Å/px. Particles extracted from Titan images were
downsampled accordingly at the time of extraction to match this
pixel size. For each particle, FOCUS calculates the expected defocus
at the center of the box based on the known tilt geometry for the 2D
crystal and exports the metadata in STAR format. The particle stack
was then imported into cryoSPARC (Punjani et al, 2017) and subject
to 2D classification into 50 classes. Particles from class averages not
clearly displaying views of the FAK 2D crystals (i.e., “bad” particles)
were excluded from further analysis, resulting in a new stack with
146,430 particles. Then, ab initio 3D map generation was performed
with two classes without symmetry, one of which displayed densi-
ties for the FERM and kinase domains and comprised 106,785 parti-
cles. This subset and respective 3D reference were further used for a
homogeneous refinement imposing C2 symmetry, with a FAK dimer
at the center of the box. Finally, the particle stack with the refined
orientations and shifts was imported into cisTEM (Grant et al, 2018)
for per-particle CTF refinement without alignments, using a resolu-
tion limit of 7 Å.
AMP-PNP dataset
After initial processing in FOCUS for tilt geometry and lattice estima-
tion, the same unit cell parameters as the apo dataset were found
for the AMP-PNP dataset. This time, 2,666,154 particles were
extracted from 2,513 selected movies after dataset pruning in
FOCUS. Particle boxes were downsampled by 2× at extraction time
to a pixel size of 2.116 Å/px in a box of 200 × 200 pixels. The parti-
cle stack was then imported into cryoSPARC and subject to 2D clas-
sification into 50 classes. Again, particles from class averages not
clearly displaying views of the FAK 2D crystals were excluded from
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further analysis, resulting in a new stack with 871,180 particles.
Interestingly, 2D classification revealed the co-existence of two dif-
ferent types of crystal packing in this dataset (Fig EV1C). Both crys-
tal packings were kept at this stage, as they cannot be interpreted
from the 2D class averages of tilted images. As in the Apo case,
ab initio 3D map generation was performed with two classes with-
out symmetry, at which stage we could disentangle the two crystal
packings. One class contained 548,394 particles (63% of the data)
and displayed clear densities for the FERM and kinase domains, in
the same crystal packing as the apo state, while the other comprised
322,786 particles (37% of the data) in a different crystal packing
that was not as well resolved. The subset of the best resolved 3D
class was then refined imposing C2 symmetry. Finally, the particle
stack of the refined map was imported into cisTEM for CTF refine-
ment without alignments like in the apo case.
Resolution estimation
Because cryoSPARC always shuffles the order of the particles for its
internal half-set assignments (this order was not changed by
cisTEM), resolution estimates were inflated due to the overlap
between particles extracted from the same 2D crystal. In order to
obtain a more reliable resolution estimate, a Python script was writ-
ten to re-assign the particles into half-sets in a per-crystal rather
than per-particle manner, and each half-set was reconstructed using
the program relion_reconstruct (He & Scheres, 2017). No refinement
of the alignment parameters was performed at this stage. Resolution
was estimated based on the Fourier shell correlation curve (Harauz
& van Heel, 1986) using the 0.143 threshold criterion (Rosenthal &
Henderson, 2003) after applying a soft-edged spherical mask on the
central FAK dimer of each map, which could not be isolated from
the map without cutting through the density of the neighboring
dimer linked via the FERM domain (Fig EV1B). Mask creation and
postprocessing operations were carried out using the program
focus.postprocess (Righetto et al, 2019), including FSC calculation,
correction for artificial correlations introduced by the mask (Chen
et al, 2013), spectral signal-to-noise ratio weighting and B-factor
sharpening based on the Guinier plot (Rosenthal & Henderson,
2003). Finally, the maps were low-pass filtered at the global cutoffs
of 6.32 Å (apo) and 5.96 Å (AMP-PNP). Local resolution was esti-
mated using the program blocres from Bsoft (Cardone et al, 2013;
Heymann & Belnap, 2007) (Fig 1C). A summary of EM data collec-
tion and processing is given in Table EV1.
Flexible fitting of atomic models
Flexible fitting of existing atomic models for the FERM domain
(PDB: 2AEH, residues 33–363) and the kinase domain (PDB: 1MP8,
residues 414–686) was performed into the obtained EM maps of
FAK in the apo and AMP-PNP states. After manual placing and
rigid-body fitting of the PDB coordinates using UCSF Chimera
(Pettersen et al, 2004), they were combined into a single PDB file
and flexibly fit using normal mode analysis in iMODFIT (Lopez-
Blanco & Chacon, 2013), followed by real space refinement in
PHENIX (Afonine et al, 2018) and manual adjustments in Coot
(Emsley & Cowtan, 2004) to improve the model geometry. Initially,
a single FAK molecule was fit following this protocol, with more
molecules later included in order to complete the dimer and the 2D
crystal supercell, always followed by a real space refinement in
PHENIX to optimize the chain interfaces. Please refer to Table EV2
for geometry and map-to-model validation scores. For the central
dimer, exhibiting the best density, linker residues 395 to 400 were
fitted bound to the FERM domains, as in 2AL6 and 2J0J (Ceccarelli
et al, 2006; Lietha et al, 2007) (Fig EV1F). The connection from 401
to 413 (beginning of the kinase was built manually based on exist-
ing density that is not continuous (Fig EV1G).
Molecular dynamics restrained by EM maps
Targeted conformational search was performed with AMBER 16
using sander.MPI, considering the cryo-EM density map as an
external potential added to the force field using EMAP implementa-
tion and self-guided Langevin dynamics (MapSLGD) (Wu et al,
2013) to accelerate the conformational search. A constant force of
0.005 kcal/g was applied only in the backbone atoms (CA, C, N,
O) to allow the side chains to interact freely. The total simulation
time was 10 ns and 1 fs time step in the NVT ensemble consider-
ing implicit solvent and a 0.9 nm cut-off using the Particle Mesh
Ewald method.
Molecular dynamics of FAK dimer on the membrane
To create models, in which Y397 is not bound to the kinase active
site, we started from the central FAK dimer from the EM structure
and filled in linker residues that were not defined using the SWISS-
MODEL server (Waterhouse et al, 2018). This is likely to represent
only one of multiple conformations of the disordered FERM-kinase
linker. To model the linker in a way that Y397 is positioned for
autophosphorylation, we added residues 391–400 into the kinase
active site based on homology to peptides bound to other tyrosine
kinases (PDB accession codes: 1IR3, 1K3A, 2PVF, 3FYG, 5CZH)
using Modeller v9.20 (Sali & Blundell, 1993) and UCSF Chimera
(Pettersen et al, 2004). We inserted the remaining residues as above
to yield models that represent either cis- or trans-binding modes.
We could not distinguish between the cis and trans models regard-
ing their propensity for autophosphorylation during subsequent
simulations. Therefore, we only show results of the trans models,
based on experimental findings (Figs 4C, and EV4A and B). We
attached PI(4,5)P2 lipids to each FERM basic patch (K216AKTLRK)
of the FAK dimers by superimposing FERM-F2 lobes with docked PI
(4,5)P2 head groups (as described here: (Goni et al, 2014)) and
adding fatty acid tails to the head groups. We incorporated the
resulting FAK-bound PI(4,5)P2 lipids into a POPC lipid bilayer
comprising 10% PI(4,5)P2 in the upper leaflet using the Charmm-
GUI Membrane Builder (Jo et al, 2007, 2008; Wu et al, 2014; Lee
et al, 2016). Using Gromacs 2016.4 (Van Der Spoel et al, 2005), we
placed the FAK dimer models including ATP and Mg2+ on a
membrane in a simulation box with dimensions 16.1
× 16.1 × 15.14 nm for bound and 16.1 × 16.1 × 16.3 nm for un-
bound models, solvated using the TIP3P water model and neutral-
ized the charge with NaCl. Subsequently, we performed steepest
descent minimization until energy convergence and Fmax below
103 kJ/mol/nm. Using Gromacs version 2018.5 and the Charmm36
force field (Klauda et al, 2010; Best et al, 2012; Huang & MacKerell,
2013), we equilibrated the minimized systems for 50 ps in the NVT
ensemble with a 1 fs time steps followed by 325 ps equilibration in
the NPT ensemble with a 2 fs time step using the velocity rescaling
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thermostat with a 1 ps coupling constant to set the temperature to
303.15 K, and the Berendsen barostat with a 5 ps coupling constant
and a compressibility of 4.5 × 105 to adjust the pressure to 1 bar.
For production simulations, we kept the temperature at 303.15 K
using the Nosé-Hoover thermostat with a coupling constant of 1 ps,
and the pressure at 1 bar using the Parrinello-Rahman barostat with
a coupling constant of 5 ps. Equations of motion were solved using
the leapfrog integrator. We froze hydrogen bonds using the LINCS
algorithm and treated the long-range electrostatics with the Particle
Mesh Ewald method with a 1.2 nm cut-off. For the calculation of
van der Waals attraction, we used a 1.2 nm cutoff transitioning the
potential to zero at the cutoff distance using the force-switch modi-
fier. The Verlet neighbor list was updated every 20 integration steps.
In simulations of bound FAK dimer models, we restrained the
distance between Pc of ATP and the hydroxyl oxygen of Y397 to
> 4.2 Å for the first 15 ns using a flat bottom harmonic potential
with a force constant of 103 kJ/mol/nm.
To determine distances and densities, we used Gromacs tools
and post-processed using the Python 3 scipy package. Contacts
between protein residues and lipids were analyzed using ConAn
(Mercadante et al, 2018).
Generation of vesicles
Vesicles were prepared at 2 mM total lipid concentration contain-
ing either 20% (mol/mol) DPPC (Echelon Biosciences) (PC vesi-
cles) or 20% (mol/mol) PI(4,5)P2 diC16 (Echelon Biosciences) (PI
(4,5)P2 vesicles), both with 80% (mol/mol) chicken egg-PC
(Avanti Polar Lipids). Solvent was removed on a rotary evaporator
and lipid films were hydrated with 20 mM Hepes (pH 7.5),
150 mM NaCl, and 1 mM Tris (2-carboxyethyl) phosphine (TCEP)
and sonicated until resuspended.
In vitro FAK auto and Src phosphorylation by ELISA
Focal adhesion kinase (WT or mutants) were first treated with
100 nM of phosphatase YopH in order to remove residual phos-
phorylation and YopH is subsequently inactivated with 1 mM
sodium orthovanadate. FAK autophosphorylation reactions were
performed using 500 nM dephosphorylated FAK proteins, 1 mM
ATP, 5 mM MgCl2 in the presence of 125 lM PC or PI(4,5)P2 vesi-
cles (12.5 lM PI(4,5)P2 on outer leaflet). Autophosphorylation
reactions were stopped after 1 min with 50 mM EDTA and phos-
phorylation levels quantified by a standard ELISA method using
anti-pFAK Y397 (Cell Signaling) and anti-FAK (Cusabio) as primary
antibodies, a HRP-conjugated secondary antibody (Dako) and TMB
(Calbiochem) for detection. After addition of 0.18 M sulfuric acid
absorption was measured at 450 nm. For Src phosphorylation reac-
tions, either only the Src kinase domain (hSrc254-536) or Src with
SH3, SH2, and kinase domains (hSrc84-536) was added equimolar
at 500 nM during the phosphorylation reactions and ELISA detec-
tion was carried out with an anti-pFAK Y577 antibody (Thermo
Fisher).
In vitro kinase assays
An enzyme-coupled spectrophotometric assay was used to deter-
mine ATP turnover of FAK proteins as described previously (Lietha
et al, 2007). In brief, reactions were performed with 1 lM kinase,
1 mM phosphoenolpyruvate, 0.25 mM NADH, 0.08 units/l pyruvate
kinase, 0.1 units/l lactate dehydrogenase, and 0.5 mM E4Y (as
polyGlu-Tyr, 4:1 Glu/Tyr; Sigma) in the presence of 125 lM PC or
PI(4,5)P2 vesicles. Reactions were initiated by adding 1 mM ATP/
5 mM MgCl2, and NADH depletion was monitored by continuous
absorption reading at 340 nm.
In vitro PI(4,5)P2-binding assay
Lipid-binding assays were performed by pull-down assays using
lipid-coated silica beads. PC and PI(4,5)P2 vesicles were generated
as described above, with the inclusion of 10% (mol/mol) dansyl-
phosphatidylethanolamine (Avanti Polar Lipids) for quantification
of lipid coating. Silica beads with 0.61 um diameter (Spherotech)
were coated at 0.05 lmol lipids/lg beads by vortexing 2 min and
incubation at 45°C on a thermomixer at 600 rpm for 30 min and
removal of unbound lipids by extensive washes. Attached lipids
were quantified on a small aliquot by removal of lipids with 1%
SDS and measuring fluorescence of the dansyl dye (excitation:
336 nm, emission: 513 nm). For pull-down assays, coated beads
containing 1.1 mM total lipid (for PI(4,5)P2-coated beads: 110 lM
PI(4,5)P2 on outer leaflet), or twofold dilutions thereof, were incu-
bated with 4 lM FAK proteins (WT or mutants) for 2 h at 4°C,
centrifuged at 1,500 g for 60s and beads washed three times with
binding buffer: 20 mM HEPES pH 7.5, 150 mM NaCl, and 1 mM
TCEP. Bound proteins were removed from beads with buffer
containing 1% SDS and protein amounts determined using a BCA
assay (Thermo Scientific).
Dynamic light scattering
Dynamic light scattering (DLS) experiments were carried out at the
Molecular Interactions Facility at the CIB Margarita Salas. The
experiments were performed using a Protein Solutions DynaPro
MS/X instrument (Protein Solutions) at 20°C and a 90° light scatter-
ing cuvette. The samples were centrifuged during 10 min at
12,000 g and 20°C immediately before measurements. Data were
collected and analyzed with the Dynamics V6 Software.
CD spectroscopy
CD spectroscopy (CD) spectra were collected on a Jasco J715
instrument between 250 and 200 nm at a protein concentration of
2.5 lM in 20 mM Tris pH 8.0, 100 mM NaCl, 5% glycerol at 20°C.
Ellipticities corrected for the buffer contribution were converted to
mean residue ellipticities using a mean molecular mass per residue
of (Mw/Naa).
Antibodies for cell biology
Antibodies used were as follows: anti-Paxillin (BD Transduction
Laboratories, NJ, USA), anti-FAK, anti-pFAK Y397, anti-pFAK Y576/
577, anti-pFAK Y925, anti-Src, anti-pSrc Y416, anti-a-Tubulin, anti-
RCAS, anti-H4, and anti-GAPDH (Cell Signaling Technologies,
Danvers, MA, USA), as well as anti-pFAK Y861 (Invitrogen, Paisley,
UK). Anti-rabbit or mouse peroxidase-conjugated secondary anti-
bodies were purchased from Cell Signaling Technologies.
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Cell culture
Focal adhesion kinase-depleted SCC cell lines were generated as
described previously (Serrels et al, 2010). Briefly, SCCs were
cultured in Glasgow MEM containing 10% FCS, 2 mM L-glutamine,
non-essential amino acids, sodium pyruvate and MEM vitamins at
37°C, 5% CO2. SCC FAK-WT and FAK mutant cells were maintained
in 1 mg/ml hygromycin B.
Whole cell lysates
Cells were washed twice in ice-cold PBS and then lysed in RIPA
buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% Triton X-100,
0.1% SDS, and 0.5% sodium deoxycholate) supplemented with
PhosStop and Complete Ultra Protease Inhibitor tablets (Roche,
Welwyn Garden City, UK). Lysates were cleared by centrifugation.
Perinuclear fractionation
The protocol was adapted and optimized from Shaiken and
Opekun (2014). All buffers were supplemented with PhosStop and
Complete Ultra Protease Inhibitor tablets (Roche, Welwyn Garden
City, UK). Cells were washed twice in ice-cold PBS and then lysed
in buffer A (20 mM Tris-HCl pH 7.5, 1 mM MgCl2, 1 mM EGTA,
0.03% NP-40), incubated for 5 min at 4°C with rotation and then
cleared by centrifugation at 800 g for 4 min. NP-40 was added to
the supernatants (cytoplasmic fraction) to give a final concentra-
tion of 1% and lysates were cleared by centrifugation. Pellets
were washed once with NP-40 containing buffer A and once with
buffer A lacking NP-40. The washed pellets were resuspended in
Buffer B (10 mM Tris-HCl pH 7.4, 1 mM KCl, 2.5 mM MgCl2,
0.2 M LiCl, 0.1% Triton X-100, 0.1% sodium deoxycholate), incu-
bated for 15 min at 4°C with rotation and then cleared by
centrifugation at 2,000 g for 5 min. The supernatants (perinuclear
fraction) were cleared by centrifugation. Pellets were washed once
in buffer B, resuspended in RIPA buffer, sonicated, and cleared
by centrifugation (nuclear fraction).
Immunoblotting and immunoprecipitation
Protein concentrations were calculated using a BCA protein assay
kit (Thermo Scientific, Loughborough, UK). For immunoprecipita-
tion, 1 mg cell lysate was incubated with 2 lg of unconjugated
anti-pSrc Y416 at 4°C overnight with agitation or with 10 ll of
agarose coupled anti-FAK or anti-Src (Millipore, Billerica, MA,
USA). Unconjugated antibody samples were incubated with 10 ll
of Protein A agarose for 1 h at 4°C. Beads were washed three
times in lysis buffer and once in 0.6 M LiCl (for pSrc Y416-IP) or
twice in lysis buffer and twice in PBS (for FAK- and Src-IPs), resus-
pended in 20 ll 2× sample buffer (130 mM Tris pH 6.8, 20% glyc-
erol, 5% SDS, 8% b-mercaptoethanol, bromphenol blue) and
heated for 5 min at 95°C. Samples were then subjected to SDS-
PAGE analysis using the Bio-Rad TGX pre-cast gel system.
Immunoblotting of the proteins occurred using the Bio-Rad Trans-
blot Turbo transfer system, blocked in 5% BSA/TBS supplemented
with 1% Tween-20, and incubated with primary antibodies over-
night at 4°C. Blots were washed three times in TBST, incubated
with peroxidase-conjugated secondary antibody for 45 min at room
temperature and washed as before. The blots were developed using
Clarity Western ECL Substrate (Bio-Rad, Hemel Hempstead, UK)
and imaged using a Bio-Rad ChemiDoc MP Imaging System (Bio-
Rad, Hemel Hempstead, UK).
Immunofluorescence microscopy and image analysis
Cells were grown on glass coverslips for 24 h and washed once in
TBS prior to fixation (3.7% formaldehyde, 100 mM PIPES pH 6.8,
10 mM EGTA, 1 mM MgCl2, and 0.2% Triton X-100) for 10 min.
The fixed cells were washed twice in TBStx (TBS supplemented
with 0.1% Triton X-100) and blocked in TBStx block (TBStx
supplemented with 3% BSA). Primary antibodies were incubated
in TBStx block over night at 4°C, followed by three washes in
TBStx, incubated with Alexa-fluor labeled secondary antibodies
diluted 1:200 in TBStx block (Life Technologies, Paisley, UK), and
washed as before. Samples were mounted in vectashield mounting
medium containing DAPI (Vector Labs, Peterborough, UK) and
imaged using a Nikon A1+ confocal microscope (Nikon, Amster-
dam, the Netherlands).
Invasion assays
Invasion was analyzed as described previously in (Serrels et al,
2010). Briefly, growth factor-reduced Matrigel (BD Biosciences,
Oxford, UK) was diluted 1:1 in ice-cold PBS and allowed to set
at 37°C in transwells. 2 × 104 cells were seeded onto the under-
side of the transwell. After 4 h, the transwells were washed in
PBS and placed into serum-free SCC growth medium with full
growth medium containing 10% FCS on top of the Matrigel.
After 72 h, cell invasion was evaluated by staining with 5 lM
calcein (Life Technologies, Paisley, UK) for 1 h. Horizontal z
sections through the Matrigel were acquired at 10 lm intervals
with an Nikon A1+ confocal microscope and analyzed using
ImageJ software.
3D proliferation assay
5 × 105 cells were resuspended in a 1.4% methylcellulose solution
in growth medium, plated on a layer of 0.9% agarose and incubated
at 37°C, 5% CO2. After 9 days, images were taken from 10 random
fields (10× magnification). Colonies were counted and the colony
size measured using ImageJ software.
Statistical tests
For all experiments shown, n = 3. Error bars for the graphs show
s.d. Student’s t-test was carried out to calculate the statistical signifi-
cance. *P < 0.01, #P < 0.05.
Data availability
The final structures and cryo-EM maps as well as raw data images
are available in the following databases:
• Protein Data Bank accession codes 6TY3 (http://www.rcsb.org/
pdb/explore/explore.do?structureId=6TY3; Apo) and 6TY4 (htt
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p://www.rcsb.org/pdb/explore/explore.do?structureId=6TY4;
AMP-PNP)
• Electron Microscopy Data Bank accession codes EMD-10615
(http://www.ebi.ac.uk/pdbe/entry/EMD-10615; apo) and EMD-
10616 (http://www.ebi.ac.uk/pdbe/entry/EMD-10616; AMP-PNP)
• Electron Microscopy Public Image Archive accession code
EMPIAR-10347 https://www.ebi.ac.uk/pdbe/emdb/empiar/
entry/10347/)
Expanded View for this article is available online.
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